TerThera
TerThera is a radionuclide production company headquartered in the Netherlands, dedicated to advancing the field of nuclear medicine. The founders and team members of TerThera bring decades of experience within the nuclear medicine industry and are fully committed to the production of the innovative radionuclide Terbium-161 (Tb-161). The company is actively establishing a global platform to address the increasing demand for radionuclides in oncology and nuclear medicine, and will be offering its product as GMP shortly.
